Relationship between MRI lesion activity and response to IFN-β in relapsing–remitting multiple sclerosis patients (Q57601943)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562504%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Relationship between MRI lesion activity and response to IFN-beta in relapsing-remitting multiple sclerosis patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562504%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

0 references

0 references

relapsing-remitting multiple sclerosis

0 references

magnetic resonance imaging

0 references

author

Jordi Rio

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562504%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Mar Tintoré

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562504%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Carmen Tur

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562504%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Xavier Montalban

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562504%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

E Huerga

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562504%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

C Nos

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562504%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

N Tellez

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562504%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

M Comabella

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562504%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

A Rovira

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562504%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

1 May 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562504%20AND%20SRC:MED&resulttype=core&format=json

Multiple Sclerosis Journal

9 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562504%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562504%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

479-484

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562504%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562504%20AND%20SRC:MED&resulttype=core&format=json

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085555

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085555

Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085555

Defining the response to interferon-β in relapsing-remitting multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085555

PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085555

Clinical characteristics of responders to interferon therapy for relapsing MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085555

Transcription-based prediction of response to IFNbeta using supervised computational methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085555

Defining interferon beta response status in multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085555

A Longitudinal Study of Abnormalities on MRI and Disability from Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085555

Predictors of long-term clinical response to interferon beta therapy in relapsing multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085555

Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085555

Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085555

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085555

The distribution of magnetic resonance imaging response to interferonβ–1b in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507085555

21 January 2018

Identifiers

DOI

10.1177/1352458507085555

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562504%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference